Viewing nowBL Atorvastatin Tablets 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Dongbang FTL Co., Ltd.

MFDS item code 201904722 · Approved 2019.07.12 · Insurance code 680500770
Improvement of hyperlipidemia (e.g., hypercholesterolemia); prevention of cardiovascular diseases
This medication helps reduce the risk of myocardial infarction, stroke, vascular surgery, and angina in adults with cardiovascular disease risk factors and patients with type 2 diabetes. It is particularly beneficial for patients with coronary artery disease or multiple risk factors and can reduce the risk of hospitalization due to congestive heart failure. Additionally, for patients with hyperlipidemia, it lowers total cholesterol and LDL cholesterol levels while increasing HDL cholesterol, thereby improving blood lipids. It is also used in pediatric patients with familial hypercholesterolemia in conjunction with dietary therapy to manage blood lipid levels. This medication is effectively used for the prevention of cardiovascular diseases and the treatment of hyperlipidemia.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (40 mg only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use at treatment initiation and when evaluating treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: Efficacy and safety in patients 70 years and older are similar to those in the general adult patient population.
Pediatric patients (10 ~ 17 years) with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). Adjust the dose as needed for each patient according to the recommended treatment goal. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle-related symptoms; if severe muscle pain or weakness is experienced, discontinue use immediately and consult a doctor. This medication may affect liver function and should not be used in patients with liver diseases or abnormally high liver function test results. Pregnant women, women who may become pregnant, and nursing mothers should not take this medication, and women of childbearing potential should use appropriate contraception during treatment. Children, especially those under 10 years of age, should not take this medication, and long-term safety has not been established in adolescents under 18 years old. This medication may interact with certain drugs; if you are taking other medications, be sure to inform your doctor or pharmacist. Particularly, elderly patients with compromised liver or kidney function may be at increased risk of muscle-related responses from this medication and should be monitored closely. If sudden muscle pain, muscle cramps, weakness, or fever occurs during treatment, notify healthcare personnel immediately and undergo testing. Caution should be exercised when using this medication in patients who consume alcohol or have certain liver diseases, and regular liver function and blood tests may be necessary. Store this medication out of the reach of children in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to keep the storage temperature between 1°C and 30°C to preserve its effectiveness.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Dongbang FTL Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.